Amniotic Membrane for the Ocular Surface

On the ocular surface, amniotic membrane performs the same role it holds in its native state: a covering and a protective barrier. Placed over the cornea, conjunctiva, or eyelid following injury or disease, an amniotic membrane allograft covers and protects the surface, and serves as a spacer between the surface and the eyelid during the recovery period. Ophthalmologists and optometrists reach for it across a range of ocular surface conditions.

Where It Is Used

Across ophthalmic practice, amniotic membrane is applied as a surface covering in settings such as persistent corneal epithelial defects, keratoconjunctivitis, chemical and thermal burns, Stevens-Johnson syndrome, high-risk trabeculectomy, and pterygium or lesion excision. It is used as a covering, protective barrier, and spacer.

An ophthalmologist consulting with a patient in an eye-care clinic

The Allograft We Represent

Allogeneic Solutions represents aril®, an acellular allograft amniotic membrane from Seed Biotech, room-temperature stable and delivered direct from the processor.

Reimbursement

Amniotic membrane transplantation to the ocular surface is a reimbursed procedure, described by CPT 65778. Coding varies by payer policy and surgical technique; current coding detail is available to clinicians on request.

Summary

A covering and protective barrier for the cornea, conjunctiva, and eyelid, represented by Allogeneic Solutions and delivered direct from the processor. Whether it fits a given case is the clinician’s call.

Acellular allograft amniotic membrane, precision-cut, single layer from Seed Biotech, room-temperature stable, and delivered directly. more

Start a Conversation

A: Because we represent the processor, not a catalog. aril® is a fully characterized acellular amniotic membrane from Seed Biotech, the FDA-registered tissue bank that makes it, delivered direct. One tissue we know completely and answer for, rather than a shelf of brands we are steps removed from.

A: Used as a covering, protective barrier, and a spacer between the ocular surface and the eyelid. These are the same structural roles amniotic membrane performs in its native state.

A: No. aril is room-temperature stable and requires no cold chain. It is a single layer of amnion with no side-specific orientation.

A: It is used across ocular-surface conditions many practices already manage, placed in-office as a covering, protective barrier, and spacer. The grafts are room-temperature stable, so there is no cold chain or special storage to add, and they are ordered per case. Placement is a reimbursed procedure described by CPT 65778, with current coding detail available on request. Whether it fits a given practice and patient is the clinician's decision.

CODING AND REIMBURSEMENT DETAILS AVAILABLE TO QUALIFIED CLINICIANS UPON REQUEST